Soergel David sold MDGL
June 1, 2026 · Form 4 insider transaction
Soergel David sold 1,042 shares of Madrigal Pharmaceuticals, Inc. at $495.74 per share, a transaction worth $516.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,042
Price
$495.74
Total value
$516.6K
InsiderSoergel David
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 1, 2026
Filing dateJune 1, 2026
Shares owned after10,033
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2026.